Furthermore, ATF2 activated through the JNK1/2 pathway plays a role in attenuating ferroptosis induced by treatments with BETi (inhibitors of bromo- and extra-terminal domain) in cancer cells and this was mediated by increased expression of NRF2 [302]. This evidence concerns the gene NFE2L2 and cancer.